Table 2 Case 2’s CK level over time and with repeated administration of aripiprazole depot
From: Aripiprazole-induced quasi-neuroleptic malignant syndrome: two case reports
Time period | Creatine kinase level (U/L) | Antipsychotic medication |
|---|---|---|
Day 1 (day of previous admission) | ||
Day 4 | Aripiprazole 400 mg depot given | |
Day 5 | 1111 | |
Day 11 | 1535 | |
Day 18 | 958 | |
4-month time frame; receiving aripiprazole 400 mg depot monthly | ||
Day | Aripiprazole 400 mg depot given in community | |
Day 14 (day of most recent admission) | ||
Day 15 | 1291 | |
Day 28 | Aripiprazole 400 mg depot given | |
Day 32 | 1168 | |